Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection

The current outbreak of severe acute respiratory distress syndrome (SARS) or nCOVID-19 pandemic, caused by the coronavirus-2 (CoV-2), continues to wreak havoc globally. As novel vaccines are being discovered and developed, small molecule drugs still constitute a viable treatment option for SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Praveen P. N., Pham, Amy Trinh, Shakeri, Arash, El Shatshat, Amna, Zhao, Yusheng, Karuturi, Rahul C., Hefny, Ahmed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827924/
https://www.ncbi.nlm.nih.gov/pubmed/33430081
http://dx.doi.org/10.3390/ph14010044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827924/
https://www.ncbi.nlm.nih.gov/pubmed/33430081
http://dx.doi.org/10.3390/ph14010044

Ejemplares similares